Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone

被引:0
|
作者
Jin Hyoung Kim
Hyung Jin Won
Yong Moon Shin
Sung Hee Kim
Hyun-Ki Yoon
Kyu-Bo Sung
Pyo Nyun Kim
机构
[1] Asan Medical Center,Department of Radiology
[2] University of Ulsan College of Medicine,Research Institute of Radiology
[3] Asan Medical Center,undefined
[4] University of Ulsan College of Medicine,undefined
来源
关键词
Tace; Local Tumor Control; Local Tumor Progression; Combine Treatment Group; Significant Independent Factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1624 / 1629
页数:5
相关论文
共 50 条
  • [1] Medium-Sized (3.1-5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone
    Kim, Jin Hyoung
    Won, Hyung Jin
    Shin, Yong Moon
    Kim, Sung Hee
    Yoon, Hyun-Ki
    Sung, Kyu-Bo
    Kim, Pyo Nyun
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (06) : 1624 - 1629
  • [2] Effectiveness of combined therapy radiofrequency ablation/transarterial chemoembolization versus transarterial chemoembolization/radiofrequency ablation on management of hepatocellular carcinoma
    El Dorry, Ahmed Kaml
    Shaker, Mohammed Kamal
    El-Fouly, Nevien Fouad
    Hussien, Ahmed
    El-Folly, Runia Fouad
    El Fouly, Amr Hafez
    Tawab, Karim Abd El
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (12) : 1573 - 1577
  • [3] Hepatocellular carcinomas 2-3 cm in diameter: Transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone
    Kim, Jong Woo
    Kim, Jin Hyoung
    Won, Hyung Jin
    Shin, Yong Moon
    Yoon, Hyun-Ki
    Sung, Kyu-Bo
    Kim, Pyo Nyun
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (03) : E189 - E193
  • [4] Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis
    Chen, Qi-Wen
    Ying, Hai-Feng
    Gao, Song
    Shen, Ye-Hua
    Meng, Zhi-Qiang
    Chen, Hao
    Chen, Zhen
    Teng, Wen-Jing
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (03) : 309 - 314
  • [5] Efficacy of Radiofrequency Ablation versus Transarterial Chemoembolization for Patients with Solitary Hepatocellular Carcinoma ≤3 cm
    Martin, Allison N.
    Wilkins, Luke R.
    Das, Deepanjana
    Johnston, Lily E.
    Bauer, Todd W.
    Adams, Reid B.
    Zaydfudim, Victor M.
    [J]. AMERICAN SURGEON, 2019, 85 (02) : 150 - 155
  • [6] Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma
    Jiang, Guisheng
    Xu, Xiaojun
    Ren, Songtao
    Wang, Li
    [J]. TUMOR BIOLOGY, 2014, 35 (04) : 3405 - 3408
  • [7] Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma
    Schwartz, Myron
    Weintraub, Joshua
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (11): : 630 - 631
  • [8] Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma
    Myron Schwartz
    Joshua Weintraub
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 630 - 631
  • [9] Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation
    Zhu, Kangshun
    Huang, Jingjun
    Lai, Lisha
    Huang, Wensou
    Cai, Mingyue
    Zhou, Jingwen
    Guo, Yongjian
    Chen, Junwei
    [J]. RADIOLOGY, 2018, 288 (01) : 300 - 307
  • [10] Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis
    Chu, Hee Ho
    Kim, Jin Hyoung
    Yoon, Hyun-Ki
    Ko, Heung-Kyu
    Gwon, Dong Il
    Kim, Pyo Nyun
    Sung, Kyu-Bo
    Ko, Gi-Young
    Kim, So Yeon
    Park, Seong Ho
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (10) : 1533 - 1543